CTOs on the Move

Versicolor Technologies

www.versicolortechnologies.com

 
Versicolor Technologies has developed the world`s first cosmetic and therapeutic technology platform to address pigmentation and skin aging, by leveraging small molecule compounds produced naturally in the human microbiome.
  • Number of Employees: 25-100
  • Annual Revenue: $1-10 Million

Executives

Name Title Contact Details

Similar Companies

Dac Medical

Dac Medical is a Southlake, TX-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Aptihealth

Aptihealth is improving higher acuity behavioral healthcare for underserved populations—one member at a time. The company`s virtual-first model and proprietary screening, assessment, and treatment programs give members fast, convenient access to precise, personalized care. Headquartered in Boston and employing over 150, aptihealth has raised over $65 million in funding from leading international equity firms. The company`s care program and data insights are driving breakthroughs in mental health understanding, treatment, outcomes, and cost reduction.

Corona-Temecula Orthopaedic Associates

Corona-Temecula Orthopaedic Associates is a Corona, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

White Memorial Medical Center

White Memorial Medical Center is a Los Angeles, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Celator Pharmaceuticals

Celator Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company that is transforming the science of combination therapy and developing products to improve outcomes for patients with cancer. The Company is working to establish a new treatment paradigm in which rationally-designed, fully-integrated combination products replace combination regimens of individual agents. Celator`s proprietary technology platform, CombiPlex®, identifies the most effective synergistic ratio of the component drugs, optimizes the pharmacology of the drug combination prior to human clinical trials, allows simultaneous administration of the components as a single product and maintains the synergistic ratio of the components after administration thereby exposing tumor cells to the right amounts of drug for the right length of time.